SCHEMBL1628564

SCHEMBL1628564

O=c1n(CC2CC2)c(=O)n(CC2CO2)c(=O)n1CC1CO1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.78
TP53 P04637 1/20 0.78
HBB P68871 1/20 0.78
DHFR P00374 1/20 0.42
PDE5A O76074 10/20 0.39
PDE4A P27815 10/20 0.39
PDE4B Q07343 10/20 0.39
PDE4C Q08493 10/20 0.39
PDE4D Q08499 10/20 0.39
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 1/20 0.34
MAPT P10636 1/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20990319 0.92 TP53 (0.72) SMN1; SMN2TP53HBBDHFRPDE5A
SCHEMBL20990321 0.90 TP53 (0.69) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL4452999 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL2097375 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL2097151 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL4932 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL4461477 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL4472568 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
Teroxirone SCHEMBL4470513 0.89 TP53 (1.00) SMN1; SMN2TP53HBBDHFRALDH1A1
SCHEMBL16169620 0.86 SMN1; SMN2 (0.58) SMN1; SMN2TP53HBBDHFRPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230324793-A1 PHOTOSENSITIVE RESIN COMPOSITION AND CURED PRODUCT ECHEM SOLUTIONS CORP. (TW) 2023-10-12 US disclosed
EP-3029084-B1 THERMOSETTING RESIN COMPOSITION, SLIDING MEMBER AND METHOD FOR PRODUCING SLIDING MEMBER MINEBEA CO LTD (JP) 2020-07-22 EP disclosed
US-10354932-B2 Semiconductor device including semiconductor element and redistribution layer electrically connected thereto, and method of manufacturing the device ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-07-16 US disclosed
US-9598538-B2 Transparent electrochromic polymer and electrochromic device INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-03-21 US disclosed
US-20170010529-A1 COLORING COMPOSITION, CURED FILM, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2017-01-12 US disclosed
US-20170010529-A1 COLORING COMPOSITION, CURED FILM, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING DEVICE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2017-01-12 US disclosed
US-20160083538-A1 Solvent Resistant, Transparent Aromatic Polyamide Films with High Refractive Indices AKRON POLYMER SYSTEMS INC (US) 2016-03-24 US disclosed
US-9218915-B2 Non-aqueous electrolyte for lithium-ion battery UCHICAGO ARGONNE, LLC (US) 2015-12-22 US disclosed
US-20150241752-A1 TRANSPARENT ELECTROCHROMIC POLYMER AND ELECTROCHROMIC DEVICE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-08-27 US disclosed
US-9040225-B2 Developable bottom antireflective coating composition and pattern forming method using thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-05-26 US disclosed
US-20140175683-A1 AROMATIC POLYAMIDE FILMS FOR SOLVENT RESISTANT FLEXIBLE SUBSTRATES AKRON POLYMER SYSTEMS, INC. (US) 2014-06-26 US disclosed
US-20140083567-A1 SOLDERING PASTE FLUX AND SOLDERING PASTE HARIMA CHEMICALS, INC. (JP) 2014-03-27 US disclosed
US-20140072915-A1 PHOTORESIST COMPOSITION CONTAINING A PROTECTED HYDROXYL GROUP FOR NEGATIVE DEVELOPMENT AND PATTERN FORMING METHOD USING THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-03-13 US disclosed
US-20130288178-A1 PHOTORESIST COMPOSITION CONTAINING A PROTECTED HYDROXYL GROUP FOR NEGATIVE DEVELOPMENT AND PATTERN FORMING METHOD USING THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2013-10-31 US disclosed
US-20130261160-A1 METHOD OF PREPARATION OF METAXALONE AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2013-10-03 US disclosed
US-20130157463-A1 NEAR-INFRARED ABSORBING FILM COMPOSITION FOR LITHOGRAPHIC APPLICATION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-06-20 US disclosed
US-20120088160-A1 NON-AQUEOUS ELECTROLYTE FOR LITHIUM-ION BATTERY UCHICAGO ARGONNE, LLC 2012-04-12 US disclosed
US-20070299162-A1 Light emitting semiconductor and encapsulant is made from nano-functionalized zirconia; silicone epoxy, epoxy isocyanurate and succinic anhydride, dodecenylsuccinic anhydride, phthalic anhydride curing agent; ancillary curing catalyst, cure modifier, coupling agent, UV, thermal stabilizer GELCORE LLC 2007-12-27 US disclosed
US-20070295983-A1 Optoelectronic device GELCORE LLC 2007-12-27 US disclosed
US-20070295956-A1 Optoelectronic device GELCORE LLC 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088160-A1 NON-AQUEOUS ELECTROLYTE FOR LITHIUM-ION BATTERY VDAC1, VDAC2, CA2 SMN1; SMN2 841/4885TP53 2732/4885HBB 3582/4885
US-20130261160-A1 METHOD OF PREPARATION OF METAXALONE MTX1, MTX2, APOL1 SMN1; SMN2 4039/4885TP53 3906/4885HBB 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.